HSD17B13 and metabolic dysfunction-associated steatotic liver disease: In addition, the study cohort allowed us to stratify and model the metabolic differences in three major genetic variants (PNPLA3, TM6SF2, and HSD17B13) associated with risk and severity of NAFLD.